From the Journals
From the Journals
Lupus may overlap in many patients with systemic sclerosis
Patients with both systemic sclerosis and systemic lupus erythematosus showed a distinct clinical phenotype from those with SSc alone, but...
From the Journals
Extra-articular RA manifestations are in decline, but mortality is still a problem
The incidence of nonsevere extra-articular manifestations of RA decreased over time, likely because of a reduced incidence of rheumatoid nodules...
From the Journals
Early glucocorticoid bridging in RA supported by meta-analysis, but concerns remain
Conflicting view: A coauthor of the 2021 American College of Rheumatology guideline says glucocorticoid treatment should be avoided if at all...
From the Journals
Hydroxychloroquine blood level ‘sweet spot’ may maximize efficacy in lupus
Researchers identified a blood-level reference range linked with 71% lower odds of active lupus.
From the Journals
Comorbidities, CV risk factors common in early PsA
Data illustrated increased odds of metabolic burden in adults newly diagnosed with psoriatic arthritis.
From the Journals
Colchicine still needed to prevent gout flares in allopurinol ‘start-low, go-slow’ strategy
Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number evened out between the two...
From the Journals
Fracture risk factors described in patients with ankylosing spondylitis
Individuals with a history of fracture were five times more likely to develop an additional fracture.
From the Journals
Osteoarthritis cases projected to balloon over next 30 years
In “a major challenge to health systems,” osteoarthritis may affect nearly 1 billion people in 2050.
From the Journals
Resident creates AI alternative to U.S. News med school ranking
After med schools dropped out of the U.S. News and World Report medical school ranking system, a resident decided to create a do-it-yourself...
From the Journals
Diabetes drug class appears to reduce recurrent gout flares
Previously associated with a lower incidence of gout, SGLT2 inhibitors for the first time also appear to reduce gout flare recurrence and excess...
From the Journals
Industry funding falls for rheumatology research
Research-associated payments dipped by 24% from 2014 to 2022, new data suggest.